Totaligent Q2 10-Q: $665 Cash, Going Concern, Aetherium Deal in Jeopardy
TGNT has more than doubled off its 52-week low of $0.004.
Summary
Totaligent's Q2 10-Q reveals $665 in cash, a going concern warning, and the Aetherium acquisition in jeopardy due to capital-raising failures. Authorized shares were increased 10x to 5 billion.
Key Events · Earnings and Guidance · TGNT
-
Cash Drops to $665
Cash fell from $4,689 at year-end to $665 at June 30, 2026. Negative working capital reached $2,198,515.
-
Going Concern Warning Reiterated
Management states substantial doubt about the company's ability to continue as a going concern within one year, citing the need for significant additional capital.
-
Aetherium Acquisition in Jeopardy
The company has been unable to raise sufficient capital to support the Aetherium business plan, making consummation of the transaction uncertain and in jeopardy.
-
Authorized Shares Increased 10x
On August 14, 2026, stockholders approved increasing authorized common shares from 500 million to 5 billion, to be completed by September 30, 2026.
Analysis · TGNT · Finance
Totaligent's Q2 report shows a company on the brink. Cash fell to $665, negative working capital ballooned to $2.2M, and the going concern warning is stark. The Aetherium acquisition—the company's strategic pivot—is now in jeopardy because Totaligent can't raise the capital needed to close. Shareholders approved a 10x increase in authorized shares to 5 billion, setting up massive future dilution. The company also disclosed a material weakness in internal controls. This is a critical update for any investor.
At the time of this filing, TGNT was trading at $0.01 on OTC in the Finance sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.00 to $0.06. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.